Novel PDE5 inhibitors for the treatment of male erectile dysfunction (Q35600579)

9 August 2017

1 reference

title

Novel PDE5 inhibitors for the treatment of male erectile dysfunction (English)

1 reference

9 August 2017

Kalsi JS

1

1 reference

9 August 2017

Bahadur G

2

1 reference

9 August 2017

Muneer A

3

1 reference

9 August 2017

Ozturk O

4

1 reference

9 August 2017

Christopher N

5

1 reference

9 August 2017

Ralph DJ

6

1 reference

9 August 2017

Minhas S

7

1 reference

9 August 2017

publication date

1 October 2003

1 reference

Reproductive BioMedicine Online

9 August 2017

published in

1 reference

9 August 2017

volume

7

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

456-461

1 reference

Physiology of penile erection

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Effects of sildenafil (Viagra) administration on seminal parameters and post-ejaculatory refractory time in normal males

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Impotence following the discovery of azoospermia.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Cyclic nucleotide phosphodiesterases: relating structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Psychological aspects of male infertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Emergency sperm extraction for transient erectile dysfunction prior to assisted conception

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Vardenafil: update on clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Sexual dysfunction in men undergoing infertility evaluation: a cohort observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

The nitric oxide and cGMP signal transduction system: regulation and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

Viagra for temporary erectile dysfunction during treatments with assisted reproductive technologies

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961890-1

7 January 2021

10.1016/S1472-6483(10)61890-1

Identifiers

DOI

1 reference

9 August 2017

1 reference